CDMO Service
Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
GMP Center
-
Purpose and production capacity
Cell & gene therapy, Vaccine
Max 1,000 lot/year (Based on the Cellid pipeline)
-
Vector GMP plant
Area : 618m2/6652ft2
Capacity : Suite 2EA (capa. 50L)
Viral vector production facility
Vaccine DS production facility
Bio Safety Level 2
Aseptic process room(Grade B)
QC Lab
-
Cell & gene therapy GMP plant
Area : 925m2/9956ft2
Capacity : Cell & gene therapy : Suite 4EA Vial filling (1500vial/hr)
Clinical & GMP run
Bio Safety Level 2, Aseptic process room(Grade B)
Closed System
Vial filling & Packaging
QC Lab
